Ruby Greywoode

Profile image for Ruby Greywoode

Ruby Greywoode, MD

Gastroenterology



Montefiore Medical Center
111 East 210th Street
Bronx, NY 10467-2401
Directions

Montefiore Einstein

About

Researcher or Academic Professional?

View Faculty Profile

Click here to learn more about this specialist's research and educational efforts at the Albert Einstein College of Medicine.

Ruby Greywoode, MD is an Attending Physician at Montefiore and Assistant Professor of Medicine at our Albert Einstein College of Medicine. Dr. Greywoode’s clinical focus is in Crohn’s disease and ulcerative colitis.

In 2007, Dr. Greywoode received her Bachelor of Arts at Princeton University. She then attended George Washington School of Medicine and Health Sciences, where she received her Doctor of Medicine in 2012. Dr. Greywoode began her postgraduate training in 2012 with a three-year internship and residency in Internal Medicine at Columbia University Medical Center. Following this, she completed a fellowship in Gastroenterology at Mount Sinai Hospital, Icahn School of Medicine in 2018.

Dr. Greywoode’s research focuses on improving the quality of inflammatory bowel disease (IBD) health care and outcomes. She is also examining how social determinants of health influence the well-being of patients with IBD. Her work has been published in a number of peer-reviewed journals..

Dr. Greywoode is board certified in gastroenterology by the American Board of Internal Medicine and is a member of the American College of Gastroenterology, the American Gastroenterological Association and the Crohn’s and Colitis Foundation of America.

Gender: Female

Credentials

Education and Training

  • Medical Education George Washington University
  • Fellowship The Mt. Sinai Hospital, NY
  • Residency Columbia Presbyterian

Areas of Expertise

Specialties

  • Gastroenterology
  • Internal Medicine

Clinical Focus

Dr. Greywoode’s clinical focus is in Crohn’s disease and ulcerative colitis.

Research Focus

Dr. Greywoode’s research focuses on improving the quality of inflammatory bowel disease (IBD) health care and outcomes. She is also examining how social determinants of health influence the well-being of patients with IBD.

Locations